|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Develops and evaluates new drugs and medical therapies. |
|
| Management |
| Stephen D. Barnhill, M.D., Chairman and Chief Executive Officer; Hong Zhang, Ph.D., Senior Vice President for Computational Medicine;
Ramananda Madyastha, M.D., Ph.D., Senior Vice President for Research & Development; Robert S. Braswell IV., Senior Vice President; Daniel R. Furth, Principal Financial Officer, Executive Vice President, Secretary and Treasurer |
| |
|
|
|
|
|
|
|
| Keywords |
| biomarker, pathway, oncology, personalized, cancer |
|
|
|
| Description |
|
Health Discovery is in the business of developing and evaluating new drugs and medical therapies. Genuinely new products must pass a series of both invitro and invivo testing in order to demonstrate their safety and effectiveness for a specific clinical application. Historically, the endpoints of these trials were 'traditional' ones tied to the actual disease being evaluated, such as a decrease in mortality or an objective/semi-objective decrease in clinical symptoms associated with the condition. In the last 10 to 15 years, there has been a move by the U.S. Food and Drug Administration to incorporate other endpoints, including biomarkers, which are nontraditional findings that are related to the presence or absence of disease. Examples of successful application of biomarker data to therapeutic evaluation include Betaseron for use against multiple sclerosis and Herceptin in the treatment of breast cancer. |
|
| Products / Services |
Using their technologies, they perform the total process of identifying a particular clinical medical problem to be solved and performing the entire process leading to the identification of the genes or proteins (called biomarkers), and the relationships among them (called pathways), that are relevant to the solution of the medical problem. This process will consist of an assessment of the clinical problem, the determination of the clinical trial set-up (the number of patients and what medical conditions they represent), the proper selection and procurement of high quality specimens for analysis, an analytical evaluation of the specimens through laboratory tests to produce the clinical data, and the mathematical evaluation of the data using pattern recognition techniques and fractal geometric modeling to produce an accurate determination of the relevant genes and proteins and the manners in which they interact.
|
|
| Technology / Differentiation |
| Health Discovery Fractal Genomics (HDFG) technology is designed to study complex biomedical genomic & protemic networks. HDFG uses a new approach toward modeling network behavior to rapidly generate diagrams and software simulations that facilitate prediction and analysis of whatever process is your particular object of study. Two important concepts behind HDFG technology are the notions of scale-free networks and self-similarity . |
|
| Market / Customers |
Stanford University, M.D. Anderson Cancer Center
|
|
| Strategy |
1) bringing together, as a scientific advisory board, a team of scientific and medical experts experienced in medicine, machine learning (artificial intelligence) and biomarker discovery,
2) creating a management team experienced in healthcare with a practical and thorough knowledge of the discovery, validation, commercialization and licensing of discovered biomarkers,
3) establishing a competent, knowledgeable and well respected board of directors,
4) building relationships with world renowned medical institutions including the capability of multi-site clinical validation of HDVY discovered biomarkers,
5) establishing focused partnerships with diagnostic and pharmaceutical companies world-wide capable of assisting in the support of the HDVY biomarker discovery process in return for project specific commercialization rights., and
6) obtaining sufficient financial capital to implement the additional programs necessary to successfully implement the biomarker discovery programs established by the Company.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
